IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

Mohammed Eslam, Reynold Leung, Manuel Romero-Gomez, Alessandra Mangia, William L. Irving, David Sheridan, Ulrich Spengler, Lindsay Mollison, Wendy Cheng, Elisabetta Bugianesi, Duncan McLeod, Abed M. Zaitoun, Vito Attino, Diane Goeltz, Jacob Nattermann, Mark Douglas, David R. Booth, Jacob George, Golo Ahlenstiel

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience

Biochemistry, Genetics and Molecular Biology